The expanding role of the transplant pharmacist in the multidisciplinary practice of transplantation

Clinical Transplantation, Supplement

Volumn 18, Issue 12, 2004, Pages 50-54

  Martin, Jill E ^a   Zavala, Edward Y ^b  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b Vanderbilt University Transplant Center   (United States)

Author keywords

Clinical practice; Compliance; Heart transplant; Kidney transplant; Liver transplant; Outcomes; Pharmacist; Transplantation

Indexed keywords

ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH SURVEY; HEART TRANSPLANTATION; HOSPITAL PATIENT; HUMAN; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MEDICAL PROFESSION; ORGAN TRANSPLANTATION; OUTPATIENT; PANCREAS TRANSPLANTATION; PATIENT CARE; PHARMACIST; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 4544293897     PISSN: 13996738     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2004.00218.x     Document Type: Article

References (14)

1. U.S. Renal Data System: USRDS 1998 Annual Data Report. Bethesda, MD: National Institutes of Health. National Institute of Diabetes Digestive and Kidney Diseases, http://www.usrds.org.
2. Leape LL, Cullen DJ, Clapp MD et al. Pharmacist participation on physician rountis and adverse drug events in the intensive care unit. JAMA 1999: 282: 267.
3. Hanlon JT, Weinberger M, Samsa GP et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med 1996: 100: 428.
4. Jameson J, Vannoord G, Vanderwoud K. The impact of a pharmacotherapy consultation on the cost and outcome of medical therapy. J Fam Pract 1995: 41: 469.
5. Ellis SL, Carter BL, Malone DC et al. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Pharmacotherapy 2000: 21: 1508.
6. Malone DC, Carter BL, Billups SJ et al. An economic analysis of a randomized, controlled, multicenter study of clinical pharmacist interventions for high-risk veterans: the IMPROVE study. Pharmacotherapy 2000: 20: 1149.
7. Koechler JA, Abramowitz PW, Swim SE, Daniels CE. Indicators for the selection of ambulatory patients who warrant pharmacist monitoring. Am J Hosp Pharm 1989: 46: 729.
8. Kaiser Family Foundation. Prescription Drug Trends - A Chartbook Update. 2001, http://www.kff.org/rxdrugs/ loader.cfm?url=commonspot/security/getfile.cfm&PageID=13796
9. Chisholm MA, Vollenweider LJ, Mulloy LL et al. Direct patient case services provided by a pharmacist on a multidisciplinary renal transplant team. AJHP 2000: 57: 1994.
10. Chisholm MA, Mulloy LL, Jagadeesan M et al. Effect of clinical pharmacy services on the blood pressure of African-American renal transplant patients. Ethn Dis 2002: 12: 392.
11. Chisholm MA, Mulloy LL, Jagadeesan M, Dipiro JT. Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications. Clin Transplant 2001: 15: 330.
12. Chisholm MA, Vollenweider LJ, Mulloy LL et al. Cost-benefit analysis of a clinical pharmacist-managed medication assistance program in a renal transplant clinic. Clin Transplant 2000: 14: 304.
13. Grabe DW, Low CL, Baile GR, Eiselle G. Evaluation of drug-related problems in an outpatient hemodialysis unit and the impact of a clinical pharmacist. Clin Nephrol 1997: 47: 117.
14. Manley HJ, Carroll CA. The clinical and economic impact of pharmaceutical care in end-stage renal disease patients. Sem Dialysis 2002: 15: 45.